Cancer-selective apoptotic effects of extracellular and intracellular Par-4

被引:0
|
作者
T Shrestha-Bhattarai
V M Rangnekar
机构
[1] Graduate Center for Toxicology,Department of Radiation Medicine
[2] University of Kentucky,Department of Microbiology
[3] University of Kentucky,undefined
[4] Immunology and Molecular Genetics,undefined
[5] University of Kentucky,undefined
[6] L. P. Markey Cancer Center,undefined
[7] University of Kentucky,undefined
来源
Oncogene | 2010年 / 29卷
关键词
Par-4; cell surface GRP78; apoptosis;
D O I
暂无
中图分类号
学科分类号
摘要
Selectivity toward cancer cells is the most desirable element in cancer therapeutics. Par-4 is a cancer cell-selective proapoptotic protein that functions intracellularly in the cytoplasmic and nuclear compartments as a tumor suppressor. Moreover, recent findings indicate that the Par-4 protein is secreted by cells, and extracellular Par-4 induces cancer cell-specific apoptosis by interaction with the cell-surface receptor GRP78. This review describes the mechanisms underlying the apoptotic effects of both extracellular and intracellular Par-4 acting through its effector domain SAC.
引用
收藏
页码:3873 / 3880
页数:7
相关论文
共 50 条
  • [1] Cancer-selective apoptotic effects of extracellular and intracellular Par-4
    Shrestha-Bhattarai, T.
    Rangnekar, V. M.
    ONCOGENE, 2010, 29 (27) : 3873 - 3880
  • [2] Cancer-Selective Apoptosis by Tumor Suppressor Par-4
    Hebbar, Nikhil
    Shrestha-Bhattarai, Tripti
    Rangnekar, Vivek M.
    ANTICANCER GENES, 2014, 818 : 155 - 166
  • [3] The phosphoinositide 3-kinase/Akt1/Par-4 axis: A cancer-selective therapeutic target
    Goswami, A
    Ranganathan, P
    Rangnekar, VM
    CANCER RESEARCH, 2006, 66 (06) : 2889 - 2892
  • [4] Novel Mechanism of Apoptosis Resistance in Cancer Mediated by Extracellular PAR-4
    Burikhanov, Ravshan
    Shrestha-Bhattarai, Tripti
    Qiu, Shirley
    Shukla, Nidhi
    Hebbar, Nikhil
    Lele, Subodh M.
    Horbinski, Craig
    Rangnekar, Vivek M.
    CANCER RESEARCH, 2013, 73 (02) : 1011 - 1019
  • [5] Synthesis, Cancer-Selective Antiproliferative and Apoptotic Effects of Some (±)-Naringenin Cycloaminoethyl Derivatives
    Zaim, Omer
    Doganlar, Oguzhan
    Zreigh, Mohamed M.
    Doganlar, Zeynep Banu
    Ozcan, Hafize
    CHEMISTRY & BIODIVERSITY, 2018, 15 (07)
  • [6] Role of PAR-4 in ovarian cancer
    Meynier, Sonia
    Kramer, Marianne
    Ribaux, Pascale
    Tille, Jean-Christophe
    Delie, Florence
    Petignat, Patrick
    Cohen, Marie
    ONCOTARGET, 2015, 6 (26) : 22641 - 22652
  • [7] Par-4 as therapy for colon cancer
    Irby, Rosalyn B.
    Kline, Christina L.
    Sharma, Arun K.
    CANCER RESEARCH, 2010, 70
  • [8] Gastrin signaling and Par-4 in pancreatic cancer
    Fino, Kristin K.
    Irby, Rosalyn B.
    Smith, Jill P.
    CANCER RESEARCH, 2011, 71
  • [9] Radiosensitivity with Par-4 expression in prostate cancer
    Sheikh, MS
    CANCER BIOLOGY & THERAPY, 2002, 1 (02) : 161 - 162
  • [10] Implication of a Pro-Apoptotic Protein, Prostate Apoptosis Response-4 (Par-4) in Breast Cancer
    Ye, L.
    Mansel, R. E.
    Jiang, W. G.
    CANCER RESEARCH, 2009, 69 (24) : 874S - 875S